Dyane Auclair

Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA

Allison C. Crawley, Briony L. Gliddon, Dyane Auclair et al. · Brain Research · 2006 · 105 citations

Knockout Mouse, Mucopolysaccharidosis Type Iiia, Pathogenesis +5

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy

Dyane Auclair · Molecular Genetics and Metabolism · 2003 · 87 citations

Early Onset, Mucopolysaccharidosis Type Vi, Pathology +2

Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study

Kim M. Hemsley, Elizabeth J. Norman, Allison C. Crawley et al. · Molecular Genetics and Metabolism · 2009 · 59 citations

Animal Physiology, Veterinary Physiology, Cisternal Sulfamidase Delivery +9

Intra-Articular Enzyme Administration for Joint Disease in Feline Mucopolysaccharidosis VI: Enzyme Dose and Interval

Dyane Auclair, Leanne K. Hein, John J. Hopwood et al. · Pediatric Research · 2006 · 38 citations · Full text

Intra-articular Enzyme Administration, Enzyme Dose, Veterinary Pathology +7

Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen

Dyane Auclair, John Finnie, Joleen T. White et al. · Molecular Genetics and Metabolism · 2009 · 38 citations

Intrathecal Injections, Immunology, Pathology +2